{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:11:52Z","timestamp":1783951912333,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,11,27]],"date-time":"2004-11-27T00:00:00Z","timestamp":1101513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s00423-004-0522-7","type":"journal-article","created":{"date-parts":[[2004,11,26]],"date-time":"2004-11-26T14:31:11Z","timestamp":1101479471000},"page":"249-254","source":"Crossref","is-referenced-by-count":63,"title":["Low molecular weight heparin-induced skin necrosis\u2014a systematic review"],"prefix":"10.1007","volume":"390","author":[{"given":"A. E.","family":"Handschin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Trentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"Kock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,11,27]]},"reference":[{"key":"522_CR1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1378\/chest.119.1_suppl.132S","volume":"119","author":"WH Geerts","year":"2001","unstructured":"Geerts WH, Anderson JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB (2001) Prevention of venous thromboembolism. Chest 119:132\u2013175, 259\u2013265","journal-title":"Chest"},{"key":"522_CR2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-135-10-200111200-00006","volume":"135","author":"RD Hull","year":"2001","unstructured":"Hull RD, Pineo GF, Stein P, Mah A, MacIsaac SM, Dahl O, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE (2001) Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 135:858\u2013869","journal-title":"Ann Intern Med"},{"key":"522_CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0140-6736(93)92614-Y","volume":"30","author":"VV Kakkar","year":"1993","unstructured":"Kakkar VV, Cohen AT, Edmonson RA, Phillips MJ, Cooper DJ, Das SK, Maher KT, Sanderson RM, Ward VP, Kakkar S (1993) Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group. Lancet 30:259\u2013265","journal-title":"Lancet"},{"key":"522_CR4","first-page":"540","volume":"73","author":"SC Litin","year":"1998","unstructured":"Litin SC, Heit JA, Mees KA (1998) Use of low molecular weight heparin in the treatment of venous thromboembolic disease: answers to frequently asked questions. Mayo Clin Proc 73:540\u2013550","journal-title":"Mayo Clin Proc"},{"key":"522_CR5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.309.6950.299","volume":"309","author":"A Leizorovicz","year":"1994","unstructured":"Leizorovicz A, Simonneau G, Decousus H, Boissel JP (1994) Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ 309:299\u2013304","journal-title":"BMJ"},{"key":"522_CR6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0025-7125(05)70015-8","volume":"82","author":"JM Walenga","year":"1998","unstructured":"Walenga JM, Bick RL (1998) Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy. Med Clin North Am 82:635\u2013658","journal-title":"Med Clin North Am"},{"key":"522_CR7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2141.2003.04334.x","volume":"121","author":"T Warkentin","year":"2003","unstructured":"Warkentin T (2003) Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121:535\u2013555","journal-title":"Br J Haematol"},{"key":"522_CR8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00002018-199920060-00005","volume":"20","author":"R Wutschert","year":"1999","unstructured":"Wutschert R, Piletta P, Bounameaux H (1999) Adverse skin reactions to low molecular weight heparins: frequency, management and prevention. Drug Saf 20:515\u2013525","journal-title":"Drug Saf"},{"key":"522_CR9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-131-12-199912210-00007","volume":"131","author":"FA McAlister","year":"1999","unstructured":"McAlister FA, Clark HD, van Walraven C, Straus SE, Lawson FM, Mosher D, Mulrow CD (1999) The medical review article revisited: has the science improved? Ann Intern Med 131:947\u2013951","journal-title":"Ann Intern Med"},{"key":"522_CR10","first-page":"1366","volume":"114","author":"F Cordoliani","year":"1987","unstructured":"Cordoliani F, Saiag P, Guillaume JC, Roujeau JC, Wechsler J, Clerici T, Touraine R (1987) Necroses cutanees etendues induites par la fraxiparine (in French). Ann Dermatol Venereol 114:1366\u20131368","journal-title":"Ann Dermatol Venereol"},{"key":"522_CR11","first-page":"751","volume":"1","author":"I Montserrat","year":"1990","unstructured":"Montserrat I, Lopez D, Zuazu-Jausoro I, Mateo J, Ribera L, Souto JC, Falcon L, Fontcuberta J (1990) Low molecular weight heparin induced skin necrosis. Blood Coagul Fibrinolysis 1:751\u2013752","journal-title":"Blood Coagul Fibrinolysis"},{"key":"522_CR12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.1992.tb06477.x","volume":"82","author":"E Ojeda","year":"1992","unstructured":"Ojeda E, Perez MC, Mataix R, Arbalo A, Jimenez S, Campo C, Bal-Da I (1992) Skin necrosis with a low molecular weight heparin. Br J Haematol 82:620","journal-title":"Br J Haematol"},{"key":"522_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0609.1994.tb00184.x","volume":"53","author":"B Balestra","year":"1994","unstructured":"Balestra B, Quadri P, Dermarmels-Biasiutti F, Furlan M, L\u00e4mmle B (1994) Low molecular weight heparin-induced thrombocytopenia and skin necrosis distant from injection sites. Eur J Haematol 53:61\u201363","journal-title":"Eur J Haematol"},{"issue":"Suppl 1","key":"522_CR14","first-page":"122","volume":"121","author":"P Koch","year":"1994","unstructured":"Koch P, Wagner S, Baum HP (1994) Necroses cutanees a l\u2019heparine et deficit en protein C? Ann Dermatol Venereol 121[Suppl\u00a01]:122","journal-title":"Ann Dermatol Venereol"},{"key":"522_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ajh.2830490316","volume":"49","author":"E Real","year":"1995","unstructured":"Real E, Grau E, Rubio M, Torrecilla T (1995) Skin necrosis after subcutaneous low molecular weight heparin injection. Am J Hematol 49:253\u2013254","journal-title":"Am J Hematol"},{"key":"522_CR16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-125-6-199609150-00036","volume":"125","author":"M Fried","year":"1996","unstructured":"Fried M, Kahanovich S, Dagan R (1996) Enoxaparin-induced skin necrosis. Ann Intern Med 125:521\u2013522","journal-title":"Ann Intern Med"},{"key":"522_CR17","first-page":"397","volume":"124","author":"I Lefebre","year":"1997","unstructured":"Lefebre I, Delaporte E, Dejobert Y, Catteau B, Piette F, Bergoend H (1997) Enoxaparin-induced cutaneous necrosis localized on insulin lipodystrophies (in French). Ann Dermatol Venereol 124:397\u2013400","journal-title":"Ann Dermatol Venereol"},{"key":"522_CR18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0190-9622(97)80011-4","volume":"37","author":"GE Gibson","year":"1997","unstructured":"Gibson GE, Gibson LE, Drage LA, Garret CR, Gertz MA (1997) Skin necrosis secondary to low molecular weight heparin in a patient with antiphospholipid antibody syndrome. J Am Acad Dermatol 37:855\u2013859","journal-title":"J Am Acad Dermatol"},{"key":"522_CR19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2796.1998.00304.x","volume":"243","author":"UJF Tietge","year":"1998","unstructured":"Tietge UJF, Schmidt HH, J\u00e4ckel C, Trautwein C, Manns MP (1998) LMWH-induced skin necrosis occurring distant from injection sites and without thrombopenia. J Intern Med 243:313\u2013315","journal-title":"J Intern Med"},{"key":"522_CR20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/106002809703100310","volume":"31","author":"ME Tonn","year":"1997","unstructured":"Tonn ME, Schaiff RA, Kollef MH (1997) Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies. Ann Pharmacother 31:323\u2013326","journal-title":"Ann Pharmacother"},{"key":"522_CR21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF00434012","volume":"116","author":"J Plath","year":"1997","unstructured":"Plath J, Schulze R, Barz D, Krammer B, Steiner M, Anders O, Mach J (1997) Necrotizing skin lesions induced by low molecular weight heparin after total knee arthroplasty. Arch Orthop Trauma Surg 116:443\u2013445","journal-title":"Arch Orthop Trauma Surg"},{"key":"522_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s002770050427","volume":"77","author":"W Fureder","year":"1998","unstructured":"Fureder W, Kyrle PA, Gisslinger H, Lechner K (1998) LMWH-induced skin necrosis. Ann Haematol 77:127\u2013130","journal-title":"Ann Haematol"},{"key":"522_CR23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000017889","volume":"196","author":"A Santamaria","year":"1998","unstructured":"Santamaria A, Romani J, Souto JC, Lopez A, Mateo J, Fontcuberta J (1998) Skin necrosis at the injection site induced by low molecular weight heparin: case report and review. Dermatology 196:264\u2013265","journal-title":"Dermatology"},{"key":"522_CR24","first-page":"266","volume":"81","author":"PJ Drew","year":"1999","unstructured":"Drew PJ, Smith MJ, Milling MA (1999) Heparin-induced skin necrosis and low molecular weight heparins. Ann R Coll Surg Engl 81:266\u2013269","journal-title":"Ann R Coll Surg Engl"},{"key":"522_CR25","first-page":"773","volume":"20\/30","author":"A Walder","year":"2001","unstructured":"Walder A, H\u00e4ttenschwiler A, Helfenstein E, Vogt M (2001) Massive Hautnekrosen nach Dalteparin Injektion (in German). Schweiz Med Forum 20\/30:773\u2013774","journal-title":"Schweiz Med Forum"},{"key":"522_CR26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0167-5273(03)00020-2","volume":"91","author":"KL Ang","year":"2003","unstructured":"Ang KL, Bose A, Halil O, Cummins D, Amrani M (2003) Low molecular weight heparin (LMWH)-induced skin necrosis in a patient with unstable angina. Int J Cardiol 91:239\u2013240","journal-title":"Int J Cardiol"},{"key":"522_CR27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1345\/aph.1C327","volume":"37","author":"SM Payne","year":"2003","unstructured":"Payne SM, Kovacs MJ (2003) Cutaneous dalteparin reactions associated with antibodies of heparin-induced thrombocytopenia. Ann Pharmacother 37:655\u2013657","journal-title":"Ann Pharmacother"},{"key":"522_CR28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-0037-1614256","volume":"91","author":"B Fontana","year":"2004","unstructured":"Fontana B, Bodmer A, Gruel Y, Boehlen F, Janer V, Kaya G, Righini M (2004) Skin necrosis is a clinical manifestation of low molecular weight heparin-induced thrombocytopenia. Thromb Haemost 91:196\u2013197","journal-title":"Thromb Haemost"},{"key":"522_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00128071-200102020-00003","volume":"2","author":"J Harenberg","year":"2001","unstructured":"Harenberg J, Hoffmann U, Huhle G, Winkler M, Bayerl C (2001) Cutaneous reactions to anticoagulants. Recognition and management. Am J Clin Dermatol 2:69\u201375","journal-title":"Am J Clin Dermatol"},{"key":"522_CR30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5694\/j.1326-5377.1984.tb104041.x","volume":"140","author":"PJ Ulrick","year":"1984","unstructured":"Ulrick PJ, Manoharan A (1984) Heparin-induced skin reaction. Med J Aust 140:287\u2013289","journal-title":"Med J Aust"},{"key":"522_CR31","first-page":"356","volume":"27","author":"KB Lim","year":"1986","unstructured":"Lim KB, Tan T (1986) Skin necrosis as a complication of improperly administered subcutaneous heparin. Singapore Med J 27:356\u2013357","journal-title":"Singapore Med J"},{"key":"522_CR32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/0003-4819-127-9-199711010-00005","volume":"127","author":"TE Warkentin","year":"1997","unstructured":"Warkentin TE, Elavathil LJ, Hayward CP, Johnston MA, Russett JI, Kelton JG (1997) The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 127:804\u2013812","journal-title":"Ann Intern Med"},{"key":"522_CR33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7326\/0003-4819-135-8_Part_1-200110160-00009","volume":"135","author":"TE Warkentin","year":"2001","unstructured":"Warkentin TE (2001) Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis. Ann Intern Med 135:589\u2013593","journal-title":"Ann Intern Med"},{"key":"522_CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1067\/mva.2001.115602","volume":"34","author":"JH Mudaliar","year":"2001","unstructured":"Mudaliar JH, Liem TK, Nichols WK, Spadone DP, Silver D (2001) Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies. J Vasc Surg 34:17\u201320","journal-title":"J Vasc Surg"},{"key":"522_CR35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archinte.164.4.361","volume":"164","author":"J Hirsh","year":"2004","unstructured":"Hirsh J, Heddle N, Kelton JG (2004) Treatment of heparin-induced thrombocytopenia\u2014a critical review. Arch Intern Med 164:361\u2013369","journal-title":"Arch Intern Med"},{"key":"522_CR36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00001721-199703000-00005","volume":"8","author":"J Amiral","year":"1997","unstructured":"Amiral J, Lormeau JC, Marfaing-Koka A, Vissac AM, Wolf M, Boyer-Neumann C, Tardy B, Herbert JM, Meyer D (1997) Absence of cross-reactivity of SR90107A\/ORG31540 pentasaccharide with antibodies to heparin\u2013PF4 complexes developed in heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis 8:114\u2013117","journal-title":"Blood Coagul Fibrinolysis"},{"key":"522_CR37","first-page":"ECR32","volume":"88","author":"R Parody","year":"2003","unstructured":"Parody R, Oliver A, Souto JC, Fontcuberta J (2003) Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Haematologica 88:ECR32","journal-title":"Haematologica"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-004-0522-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-004-0522-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-004-0522-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T09:32:53Z","timestamp":1585992773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-004-0522-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,27]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1007\/s00423-004-0522-7","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,27]]}}}